Pharmaxis Ltd - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Pharmaxis Ltd Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Pharmaxis Ltd. The Group's principal activities are researching, developing and commercializing human healthcare products for the treatment and management of chronic respiratory and immune disease. Products include Aridol and Bronchitol. Aridol is designed to help doctors diagnose and manage asthma by detecting active airway inflammation through measuring airway hyper-responsiveness. Bronchitol is a drug designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions. The Group operates predominantly in Australia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report